Cargando…

Serum CA125 Concentration has Inverse Correlation with Metabolic Syndrome

Serum carbohydrate antigen 125 (CA-125) is a marker of ovarian cancer and obesity that is related with an increased risk of ovarian cancer. Obesity is a key factor of metabolic syndrome. We evaluated the relationship between CA-125 concentration and metabolic syndrome. The data from subjects who had...

Descripción completa

Detalles Bibliográficos
Autores principales: Joo, Nam-Seok, Kim, Kyu-Nam, Kim, Kyung Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192345/
https://www.ncbi.nlm.nih.gov/pubmed/22022186
http://dx.doi.org/10.3346/jkms.2011.26.10.1328
_version_ 1782213741845151744
author Joo, Nam-Seok
Kim, Kyu-Nam
Kim, Kyung Soo
author_facet Joo, Nam-Seok
Kim, Kyu-Nam
Kim, Kyung Soo
author_sort Joo, Nam-Seok
collection PubMed
description Serum carbohydrate antigen 125 (CA-125) is a marker of ovarian cancer and obesity that is related with an increased risk of ovarian cancer. Obesity is a key factor of metabolic syndrome. We evaluated the relationship between CA-125 concentration and metabolic syndrome. The data from subjects who had any cancer and chronic infection were excluded. The data of 12,196 healthy Korean women were analyzed. After CA-125 concentration was divided by quartiles, the prevalence of metabolic syndrome and its components were compared. The lowest quartile of CA-125 compared with the highest quartile showed elevated values of most of metabolic parameters. In addition, as the quartile of CA-125 increased, metabolic derangement decreased. Increased numbers of metabolic syndrome components showed an inverse association with CA-125 levels (P < 0.001). The odds ratio (OR) for the lowest CA-125 quartile vs the highest CA-125 quartile significantly increased in the presence of metabolic syndrome (OR = 1.202, 95% Confidence Interval [CI] 1.013-1.423), elevated triglyceride (OR = 1.381, 95% CI 1.167-1.633), and low high-density lipoprotein cholesterol (OR = 1.168, 95% CI 1.039-1.312). The presence of metabolic syndrome, elevated triglyceride, or low high-density lipoprotein cholesterol negatively correlates with CA-125 concentration.
format Online
Article
Text
id pubmed-3192345
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-31923452011-10-21 Serum CA125 Concentration has Inverse Correlation with Metabolic Syndrome Joo, Nam-Seok Kim, Kyu-Nam Kim, Kyung Soo J Korean Med Sci Original Article Serum carbohydrate antigen 125 (CA-125) is a marker of ovarian cancer and obesity that is related with an increased risk of ovarian cancer. Obesity is a key factor of metabolic syndrome. We evaluated the relationship between CA-125 concentration and metabolic syndrome. The data from subjects who had any cancer and chronic infection were excluded. The data of 12,196 healthy Korean women were analyzed. After CA-125 concentration was divided by quartiles, the prevalence of metabolic syndrome and its components were compared. The lowest quartile of CA-125 compared with the highest quartile showed elevated values of most of metabolic parameters. In addition, as the quartile of CA-125 increased, metabolic derangement decreased. Increased numbers of metabolic syndrome components showed an inverse association with CA-125 levels (P < 0.001). The odds ratio (OR) for the lowest CA-125 quartile vs the highest CA-125 quartile significantly increased in the presence of metabolic syndrome (OR = 1.202, 95% Confidence Interval [CI] 1.013-1.423), elevated triglyceride (OR = 1.381, 95% CI 1.167-1.633), and low high-density lipoprotein cholesterol (OR = 1.168, 95% CI 1.039-1.312). The presence of metabolic syndrome, elevated triglyceride, or low high-density lipoprotein cholesterol negatively correlates with CA-125 concentration. The Korean Academy of Medical Sciences 2011-10 2011-10-01 /pmc/articles/PMC3192345/ /pubmed/22022186 http://dx.doi.org/10.3346/jkms.2011.26.10.1328 Text en © 2011 The Korean Academy of Medical Sciences. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Joo, Nam-Seok
Kim, Kyu-Nam
Kim, Kyung Soo
Serum CA125 Concentration has Inverse Correlation with Metabolic Syndrome
title Serum CA125 Concentration has Inverse Correlation with Metabolic Syndrome
title_full Serum CA125 Concentration has Inverse Correlation with Metabolic Syndrome
title_fullStr Serum CA125 Concentration has Inverse Correlation with Metabolic Syndrome
title_full_unstemmed Serum CA125 Concentration has Inverse Correlation with Metabolic Syndrome
title_short Serum CA125 Concentration has Inverse Correlation with Metabolic Syndrome
title_sort serum ca125 concentration has inverse correlation with metabolic syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192345/
https://www.ncbi.nlm.nih.gov/pubmed/22022186
http://dx.doi.org/10.3346/jkms.2011.26.10.1328
work_keys_str_mv AT joonamseok serumca125concentrationhasinversecorrelationwithmetabolicsyndrome
AT kimkyunam serumca125concentrationhasinversecorrelationwithmetabolicsyndrome
AT kimkyungsoo serumca125concentrationhasinversecorrelationwithmetabolicsyndrome